Endocare launches cryoablation system in China:
This article was originally published in Clinica
Endocare has launched its CRYOcare system for the treatment of metastatic liver cancer in China. The Irvine, California-based company has already set up a training centre and sold systems to select surgical centres. It has also formed a distribution agreement with Charlson International, which is based in Hong Kong. Endocare says the Chinese market is attractive because the incidence of liver cancer is extremely high compared with Western countries. Around 10% of the more than 100 million chronic carriers of the Hepatitis B virus in China are expected to develop primary liver cancers, says Endocare.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.